Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1991-6-7
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0028-3878
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
766
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2027504-Alzheimer Disease,
pubmed-meshheading:2027504-Antibodies, Anti-Idiotypic,
pubmed-meshheading:2027504-Humans,
pubmed-meshheading:2027504-Immunoglobulin M,
pubmed-meshheading:2027504-Motor Neurons,
pubmed-meshheading:2027504-Nervous System Diseases,
pubmed-meshheading:2027504-Neuromuscular Diseases,
pubmed-meshheading:2027504-Parkinson Disease
|
pubmed:year |
1991
|
pubmed:articleTitle |
Anti-GM1 antibodies.
|
pubmed:publicationType |
Letter,
Comment
|